Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06920147 · ClinicalTrials.gov registry record · Phase 4
PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
NCT06920147 is a Phase 4 study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 300 participants.
The verdict
NCT06920147, a Phase 4 study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of 2 prophylactic antibiotic regimens, ertapenem and cefazolin with metronidazole, in preventing organ space surgical site infections (OS-SSI) after emergency trauma laparotomy embedded into routine clinical care and to validate a Bayesian OS-SSI risk calculator using Trauma Quality Improvement Program (TQIP) standardized variables
Interventions
- DRUG Ertapenem
- DRUG Cefazolin and Metronidazole.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06920147
The ClinicalTrials.gov registry entry for NCT06920147 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ertapenem is the first listed.
NCT06920147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06920147 about?
NCT06920147 is a clinical study titled "PRevention Of Trauma-related Infections Through an Embedded Clinical Trials Network". The purpose of this study is to compare the effectiveness of 2 prophylactic antibiotic regimens, ertapenem and cefazolin with metronidazole, in preventing organ space surgical site infections (OS-SSI) after emergency trauma laparotomy embedded into routine clinical care and to validate a Bayesian OS...
What is the current status of trial NCT06920147?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2025-05-01. Estimated completion is 2027-03-31.
What interventions are being tested in trial NCT06920147?
The interventions under investigation include: Ertapenem (DRUG), Cefazolin and Metronidazole. (DRUG).
Who is sponsoring clinical trial NCT06920147?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.